INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 161 filers reported holding INTERSECT ENT INC in Q2 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,739,000 | +14.0% | 54,100 | 0.0% | 0.25% | -2.0% |
| Q4 2018 | $1,525,000 | -1.9% | 54,100 | 0.0% | 0.25% | +40.2% |
| Q3 2018 | $1,555,000 | -26.7% | 54,100 | -4.4% | 0.18% | -22.8% |
| Q2 2018 | $2,120,000 | -8.7% | 56,600 | -4.2% | 0.23% | -15.9% |
| Q1 2018 | $2,323,000 | +21.3% | 59,100 | 0.0% | 0.28% | +9.5% |
| Q4 2017 | $1,915,000 | +4.0% | 59,100 | 0.0% | 0.25% | -13.1% |
| Q3 2017 | $1,841,000 | -26.1% | 59,100 | -33.7% | 0.29% | -32.2% |
| Q2 2017 | $2,490,000 | +83.5% | 89,100 | +12.6% | 0.43% | +51.2% |
| Q1 2017 | $1,357,000 | +37.8% | 79,100 | +27.1% | 0.28% | +26.9% |
| Q3 2016 | $985,000 | +22.5% | 62,213 | 0.0% | 0.22% | +13.8% |
| Q2 2016 | $804,000 | -32.0% | 62,213 | 0.0% | 0.20% | -30.5% |
| Q1 2016 | $1,182,000 | -18.9% | 62,213 | -4.0% | 0.28% | -17.1% |
| Q4 2015 | $1,458,000 | – | 64,813 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 238,698 | $3,781,000 | 3.74% |
| PURA VIDA INVESTMENTS, LLC | 275,000 | $4,356,000 | 1.32% |
| Broadfin Capital, LLC | 638,600 | $10,115,000 | 0.91% |
| Aisling Capital LLC | 248,498 | $3,936,000 | 0.81% |
| Bellevue Group AG | 205,325 | $3,252,000 | 0.59% |
| Iguana Healthcare Management, LLC | 180,000 | $2,852,000 | 0.51% |
| Rock Springs Capital Management LP | 345,000 | $5,465,000 | 0.34% |
| SECTORAL ASSET MANAGEMENT INC | 168,140 | $2,663,000 | 0.26% |
| FORMULA GROWTH LTD | 62,213 | $985,000 | 0.22% |
| MENTA CAPITAL LLC | 111,915 | $1,773,000 | 0.17% |